|
Volumn 20, Issue 3, 2001, Pages 257-268
|
The west midlands "severe hypertensive illness in pregnancy" (SHIP) audit
a a b c d a a |
Author keywords
Adverse outcome; Audit; Severe Hypertensive Illness in Pregnancy
|
Indexed keywords
ATENOLOL;
BENZODIAZEPINE DERIVATIVE;
HYDRALAZINE;
LABETALOL;
MAGNESIUM SULFATE;
METHYLDOPA;
NIFEDIPINE;
PHENYTOIN;
ARTICLE;
BLOOD PRESSURE MONITORING;
ECLAMPSIA;
FEMALE;
FLUID BALANCE;
HELLP SYNDROME;
HUMAN;
LOW BIRTH WEIGHT;
MAJOR CLINICAL STUDY;
MATERNAL HYPERTENSION;
MATERNAL MORTALITY;
MEDICAL AUDIT;
OXYGEN SATURATION;
PATIENT CARE;
PERINATAL MORTALITY;
PRACTICE GUIDELINE;
PREECLAMPSIA;
PREMATURITY;
ADULT;
ANTIHYPERTENSIVE AGENTS;
ECLAMPSIA;
ENGLAND;
FEMALE;
HELLP SYNDROME;
HUMANS;
MEDICAL AUDIT;
PRE-ECLAMPSIA;
PREGNANCY;
PREGNANCY OUTCOME;
|
EID: 0035666055
PISSN: 10641955
EISSN: None
Source Type: Journal
DOI: 10.1081/PRG-100107828 Document Type: Article |
Times cited : (12)
|
References (26)
|